Mr & Mrs Aditya Dhar visits Baglamukhi Mata Mandir
Aug 26, 2022UK approves Moderna's Omicron-specific Covid booster
Aug 16, 2022British health authorities stated on Monday that the UK has become the first nation to approve a so-called "bivalent" COVID vaccine that targets both the original strain of COVID-19 and the more recent Omicron version. The Moderna vaccine was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) as a "sharpened instrument" against the new coronavirus after it was determined to meet its requirements of safety, quality, and effectiveness. According to the regulator, half of the booster dose of the "Spikevax bivalent Original/Omicron" vaccine (25 micrograms) is directed against the original viral strain from 2020 and the other half is directed at Omicron. "I am happy to announce that the Moderna bivalent booster vaccination has been approved in the clinical trial to provide a strong immune response against the Omicron BA.1 variant as well as the original 2020 strain,” said MHRA Chief Executive Dr June Raine. The first generation of COVID-19 vaccinations, which are still in use in the UK, continue to offer vital disease protection and save lives. As the virus continues to develop, this bivalent vaccine gives us a more effective weapon in our arsenal to help defend us against this disease, she said. The Commission on Human Medicines, an independent, professional scientific advisory body that advises the government, approved the MHRA's decision to appr